MTOR and gastric cancer: A mechanism of immunotherapy resistance in gastric cancer has been reported, in which activation of the PI3K/Akt/mTOR pathway increases the production of free fatty acids, which are taken up more efficiently by regulatory T cells than by effector T cells, resulting in an increase in regulatory T cells in the tumor [32, 33].